期刊文献+

RVVC缓解期阴道局部IL-4、IL-12、IFN-γ水平异常及临床意义初探 被引量:10

Study on level of IL-4,IL-12 and IFN-γ cytokines in vaginal lavage fluid of women with recurrent vulvovaginal candidiasis during paracmasia
下载PDF
导出
摘要 目的:探讨复发性外阴阴道假丝酵母菌病(RVVC)缓解期女性阴道局部IL-4、IL-12、IFN-γ的水平。方法:采集缓解期RVVC女性卵泡期(RVVC缓卵泡期组)、黄体期(RVVC缓黄体期组)阴道灌洗液,以黄体期健康女性为正常对照(正常组),采用酶联免疫法(ELISA法)检测阴道局部IL-4、IL-12、IFN-γ水平。结果:IL-12和IFN-γ的水平在缓解期RVVC黄体期组均高于正常组(P<0.05),缓解期RVVC卵泡期组和正常组间相比无明显差异(P>0.05),缓解期RVVC卵泡期组和黄体期组间相比无明显差异(P>0.05);IL-4和IFN-γ/IL-4比值在三组间比较无差异(P>0.05)。结论:RVVC患者存在一定的阴道局部免疫功能失调,以黄体期表现明显,故推测在此期进行巩固治疗可以提高临床疗效。 Objective:To investigate the level of vaginal concentration of cytokines and vaginal local immunity in Recurrent Vulvovaginal Candidiasis ( RVVC ) during paracmasia. Methods: Vaginal lavage fluid (VLF) samples were obtained from 46 women with RVVC during paracmasia, of which 23 cases were during the follicular phase ( Follicular phase group) and 23 cases were during the luteal phase(luteal phase group). The healthy women during the luteal phase act as the normal control. Concentration of IL-4, IL-12 and IFN-γ were measured using enzyme-linked immunosorbent assay kits. Data was analysed by One-Way ANOVA or Kruskal-Wallis tests ,P 〈 0.05 was considered significant. Results: Concentrations of IL-12 and IFN-γ in the VLF of women with RVVC during the lu- teal phase were significantly higher than the women of the normal control during paracmasia( P 〈 0.05 ). There was no difference be- tween the follicular phase of women with RVVC in remission and the control group in the concentration of IL-12 and IFN-γ The results did not differ between the women during the follicular phase and one during the luteal phase. The level of IL-4 and IFN-γ/IL4 among the three groups were not statistically different ( P 〉 O. 05 ). Conclusion: These results indicate that the vagina local immunity function of RVVC female probably were disorder, especially during the luteal phase of the menstrual cycle, so we may had better choose this stage to consolidation therapy.
作者 阮丽君 朱玲
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2014年第3期388-391,共4页 Chinese Journal of Immunology
基金 广东省科技计划项目(No.2011B061300097) 广东省人口和计划生育委员会科研项目(No.2010333)
关键词 复发性外阴阴道假丝酵母菌病 细胞因子 阴道免疫 月经周期 Recurrent vulvovaginal candidosis Cytokines Vaginal immunity Menstrual cycle
  • 相关文献

参考文献8

  • 1丰有吉.妇产科学[M].第2版,北京:人民卫生出版社,2011,276.
  • 2刘朝晖,王晓莉,廖秦平.外阴阴道假丝酵母菌病患者阴道局部免疫环境状态研究[J].中华妇产科杂志,2006,41(12):843-844. 被引量:47
  • 3Spacek J , Buchta V, Jilek P , et at. Clinical aspects and luteal phase assessment in patients with recurrent vulvovaginal candidiasis [J] . Eur J Obstet Gynecol Reprod Bioi ,2007,131 (2) : 198-202.
  • 4Anton G, Rid J, Mylonas I, et at. Evidence of a Thl-shift of local vaginal inflammatory response during bacterial vaginosis [J] . Infec- tion,2008,36(2) :147-152.
  • 5Nawrot U, Grzybek - Hryncewicz K, Zielska U, et at. The study of cell-mediated immune response in recurrent vulvovaginal candidia- sis[J]. FEMS Immunol Med Microbiol,2000 ,29(2) :89-94.
  • 6Fidel PL Jr, Barousse M, Lounev V, et at. Local immune responsiveness following intravaginal challenge with Candida antigen in adult women at different stages of the menstrual cycle [J] . Med M y- col ,2003,41 (2) : 102.
  • 7Clancy R, Corrigan E, Dunkey M. Recurrent vulvovaginal candidiasis-allergy or immune deficiency? [J] . Int Arch Allergy Immunol, 1999,118 :349-350.
  • 8金伯泉.医学免疫学[M].北京:人民卫生出版社,2009.133-134.

二级参考文献9

  • 1Fratti RA,Ghannoum MA,Edwards JE Jr,et al.Gamma interferon protects endothelial cells from damage by Candida albicans by inhibiting endothelial cell phagocytosis.Infect Immun,1996,64:4714-4718.
  • 2Clift RA.Candidiasis in the transplant patient.Am J Med,1984,77:34-38.
  • 3Nawrot U,Grzybek-Hryncewicz K,Zielska U,et al.The study of cell-mediated immune response in recurrent vulvovaginal candidiasis.FEMS Immunol Med Microbiol,2000,29:89-94.
  • 4Polonelli L,De Bernadis F,Conti S,et al.Human natural yeast killer toxin-like cadidicidal antibodies.J Immunol,1996,156:1880-1885.
  • 5Fidel PL Jr,Luo W,Chabain J,et al.Use of cellular depletion analysis to examine circulation of immune effector function between the vagina and the periphery.Infect Immun,1997,65:3939-3943.
  • 6Cassone A,Boccanera M,Adriani D,et al.Rats clearing a vaginal infection by Candida albicans acquire specific,antibody-mediated resistance to vaginal infection.Infect Immun,1995,63:2619-2624.
  • 7Wozniak KL,Wormley FL Jr,Fidel PL Jr.Candida-specific antibodies during experimental vaginal candidiasis in mice.Infect Immun,2002,70:5790-5799.
  • 8Romani L,Mencacci A,Cenci E,et al.CD4+ subset expression in murine candidiasis.Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance.J Immunol,1993,150:925-931.
  • 9Kalo-Klein A,Witkin SS.Candida albicans:cellular immune system interactions during different stages of the menstrual cycle.Am J Obstet Gynecol,1989,161:1132-1136.

共引文献109

同被引文献85

  • 1齐金羚,王巍.桂芍四妙汤联合复方沙棘籽油栓治疗霉菌性阴道炎疗效及对细胞因子水平影响[J].辽宁中医药大学学报,2021,23(11):211-214. 被引量:15
  • 2中华妇产科学分会感染性疾病协作组.外阴阴道念珠菌病诊治规范(草案)[J].中华妇产科杂志,2004,39(6):430-431. 被引量:490
  • 3祁文瑾,石一复.念珠菌性外阴阴道炎的免疫学研究[J].国外医学(妇幼保健分册),2004,15(4):214-216. 被引量:14
  • 4Foxman B, Muraglia R, Dietz JP, et al. Prevalence of recurrent vul- vovaginal candidiasis in 5 european countries and the united states:results from an internet panel survey[ J]. J Low Genit Tract Dis,2013,17(3) :340-5.
  • 5Weissenbaeher TM, Witkin SS, Gingel maier A, et al. Relationship between recurrent vulvovaginal caudidosis and immune mediators in vaginal fluid[J]. Eur J Obstet Gynecol Reprod Biol,2009,144 ( 1 ) :59-63.
  • 6Fidel PL Jr, Barousse M, Espinosa T, et al. An intravaginal live candid challenge in humans leads to new hypotheses for the immu- nopathogenesis of vulvovaginal candidiasis [ J ]. Infect Immun, 2004,72 ( 5 ) :2939-2946.
  • 7Amouri I, Hadrich I, Abbes S, et al. Local humoral immunity in vulvovaginal candidiasis [ J ] . Ann Biol Clin ( Paris ) , 2013,71 (2) :151-155.
  • 8Sandini S, La Valle R, Deaglio S, et al. A highly immunogenic re- combinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine[ J]. Immunol Med Microbio1,2011,62 ( 2 ) :215-224.
  • 9Donders GG, Mertens I, Bellen G,et al. Self-elimination of risk factors for recurrent vaginal candidosis [ J ]. Mycoses, 2011,54 ( 1 ):39-45.
  • 10SPacek J, Buehta V, Jilek P, et al. Clinical aspect and luteal Phase assessment in Patients with recurrent vulvovaginal candidiasis [ J ] . Eur J Obstet Gynecol Reprod Biol, 2007, 131 (2) :198-202.

引证文献10

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部